Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Periodontal Bone Loss: early-phase trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Periodontal Bone Loss: 1 US clinical trial tracked, none currently recruiting.

Periodontal Bone Loss is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Nebraska, running 1 of these trials.

Enrollment posture brief

Registry condition periodontal-bone-loss

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Periodontal Bone Loss (this)0%
Open-enrollment share among volume-matched conditions near Periodontal Bone Loss

Periodontal Bone Loss has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Periodontal Bone Loss on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Periodontal Bone Loss is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Periodontal Bone Loss records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Enamel Matrix Proteins Derivative Drug
1 trials
Saline Other
1 trials

US sites by state

Facility locations filed on Periodontal Bone Loss trials. A trial with sites in several states counts in each.

Nebraska 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Periodontal Bone Loss page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Periodontal Bone Loss trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • University of Nebraska sponsors the most Periodontal Bone Loss trials on record, review their full trial history before evaluating a specific study. See University of Nebraska's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Periodontal Bone Loss condition card totals 1 registered trials; most-linked intervention Enamel Matrix Proteins Derivative; top US site state Nebraska. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.